Thyrocare Technologies’ shares surged nearly 13% on Wednesday after the company reported strong Q1 results for the quarter ended June 30, 2024. The company’s net profit rose 38.8% year-on-year to ₹24 crore, up from ₹17 crore in the same period last year, surpassing Bloomberg analysts’ estimate of ₹22 crore.
Revenue for the quarter increased by 16.3% to ₹157 crore, compared to ₹135 crore a year ago. The EBITDA also saw a significant rise of 23.5%, reaching ₹43 crore from ₹35 crore, with the EBITDA margin improving to 27.2% from 25.6%. Additionally, Thyrocare’s earnings per share (EPS) increased to ₹4.52 from ₹3.25 in June 2023.
As of 12:17 PM, Thyrocare’s shares were trading 13% higher, reflecting strong market confidence in the company’s performance and growth prospects.
